missing translation for 'onlineSavingsMsg'
Learn More

STEMCELL Technologies BSI-201

Código de producto. 17130332
Encompass_Preferred
Change view
Click to view available options
Cantidad:
50 mg
Tamaño de la unidad:
50 miligramos
Código de producto. Cantidad unitSize
17130332 50 mg 50 miligramos
1 options
Este artículo no se puede devolver. Vea la política de devoluciones

Código de producto. 17130332

Marca: STEMCELL Technologies 74122

Por favor, para comprar este producto. ¿No tiene usuario web? Regístrese hoy mismo.

This item is not returnable. View return policy

Cysteine-containing protein modifier; Inhibits growth of triple-negative breast cancer cells

  • BSI-201, also known as iniparib, can interact with the zinc finger domain of poly(ADP-ribose) polymerase 1 (PARP1) in vitro, but fails to inhibit the enzyme (Patel et al.) The nitroso metabolite of BSI-201 is highly reactive and forms non-specific covalent interactions with many cysteine-containing proteins (Liu et al.) BSI-201 has demonstrated anti-proliferative effects in triple-negative breast cancer cells (Chuang et al.; Yin et al.), and early studies indicated that it may be useful in treating early-stage triple-negative and BRCA1/2 mutation-associated breast cancer (O'Shaughnessy et al. 2009); however, its efficacy was later found to be insignificant (O'Shaughnessy et al.) 2014)

Specifications

CAS 160003-66-7
Sinónimo Iniparib; IND 71677
Cantidad 50 mg
Fórmula molecular C7H5IN2O3
Pureza ≥98%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.